YWHAQ Gene

Migration, Crosslink

📖

YWHAQ Gene

active

wiki page Created: 2026-04-02T07:19:28 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-ywhaq

📖 Wiki Page

gene1555 wordssynced 2026-04-02

YWHAQ (Tyrosine 3-Monooxygenase/tryptophan 5-Monooxygenase Activation Protein Theta)

Overview

flowchart TD YWHAQ["YWHAQ"] -->|"regulates"| Nuclear_Cytoplasmic_Shuttling["Nuclear-Cytoplasmic Shuttling"] YWHAQ["YWHAQ"] -->|"binds"| TARDBP["TARDBP"] YWHAQ["YWHAQ"] -->|"promotes"| Tardbp_Cytoplasmic_Accumulatio["Tardbp Cytoplasmic Accumulation"] YWHAQ["YWHAQ"] -->|"promotes"| Tdp_43_Phosphorylation["Tdp-43 Phosphorylation"] YWHAQ["YWHAQ"] -->|"promotes"| Tardbp_Fragmentation["Tardbp Fragmentation"] YWHAQ["YWHAQ"] -->|"mediates"| Amyotrophic_Lateral_Sclerosis["Amyotrophic Lateral Sclerosis"] YWHAQ["YWHAQ"] -->|"mediates"| Frontotemporal_Dementia["Frontotemporal Dementia"] YWHAQ["YWHAQ"] -->|"biomarker for"| Amyotrophic_Lateral_Sclerosis["Amyotrophic Lateral Sclerosis"] YWHAQ["YWHAQ"] -->|"biomarker for"| Frontotemporal_Dementia["Frontotemporal Dementia"] style YWHAQ fill:#4fc3f7,stroke:#333,color:#000

YWHAQ (Tyrosine 3-Monooxygenase/tryptophan 5-Monooxygenase Activation Protein Theta), also known as 14-3-3 theta (epsilon), encodes a member of the 14-3-3 protein family—a group of highly conserved dimeric scaffold proteins that regulate critical cellular processes including signal transduction, cell cycle progression, apoptosis, and neuronal function["@foote2020"]. The 14-3-3 theta isoform is widely expressed in the central nervous system and has emerged as an important player in neurodegeneration, with roles in Alzheimer's disease, Parkinson's disease, and various protein aggregation disorders["@yau2015"].

...

YWHAQ (Tyrosine 3-Monooxygenase/tryptophan 5-Monooxygenase Activation Protein Theta)

Overview

Mermaid diagram (expand to render)

YWHAQ (Tyrosine 3-Monooxygenase/tryptophan 5-Monooxygenase Activation Protein Theta), also known as 14-3-3 theta (epsilon), encodes a member of the 14-3-3 protein family—a group of highly conserved dimeric scaffold proteins that regulate critical cellular processes including signal transduction, cell cycle progression, apoptosis, and neuronal function["@foote2020"]. The 14-3-3 theta isoform is widely expressed in the central nervous system and has emerged as an important player in neurodegeneration, with roles in Alzheimer's disease, Parkinson's disease, and various protein aggregation disorders["@yau2015"].

The 14-3-3 proteins constitute a family of seven isoforms in mammals (alpha, beta, gamma, delta, epsilon, eta, theta), each encoded by separate genes. YWHAQ specifically encodes the theta isoform, which is predominantly expressed in neural tissue and has been implicated in both protective and pathogenic mechanisms in neurodegenerative diseases["@steinacker2011"].

| Property | Value |
|----------|-------|
| Gene Symbol | YWHAQ |
| Full Name | Tyrosine 3-Monooxygenase/tryptophan 5-Monooxygenase Activation Protein Theta |
| Chromosomal Location | 2p25.2 |
| NCBI Gene ID | 10971 |
| Ensembl ID | ENSG00000108774 |
| UniProt ID | P27348 |
| OMIM | 609505 |
| Protein Name | 14-3-3 protein theta |
| Gene Type | Protein-coding |
| Protein Family | 14-3-3 family |

</div>

Gene and Protein Structure

Gene Organization

The YWHAQ gene is located on chromosome 2p25.2 and encodes a protein of approximately 245 amino acids with a molecular weight of ~28 kDa[@berg1989]. The gene structure is conserved across vertebrates, and the protein belongs to the 14-3-3 family of adaptor/scaffold proteins.

Protein Architecture

14-3-3 proteins are characterized by their unique structure:

N-terminal dimerization domain: Mediates formation of homodimers and heterodimers

Central amphipathic groove: Forms the phosphoserine/phosphothreonine binding pocket

C-terminal regulatory region: Involved in protein-protein interactions

The 14-3-3 proteins recognize phosphorylated serine/threonine motifs on target proteins, specifically the consensus sequences RXXpS/pT and RXSXP[@layfield2003]. This phosphorylation-dependent binding allows 14-3-3 proteins to regulate the activity, localization, and stability of numerous target proteins.

Structural Features

14-3-3 theta shares the characteristic fold of the family:

Homo-dimeric structure: Each monomer ~28 kDa, forms a barrel-like dimer
Phosphopeptide binding pocket: Recognizes phosphorylated motifs on substrates
Multiple interaction surfaces: Enable simultaneous binding to multiple partners
High affinity for phosphorylated targets: KD in the nanomolar range

Molecular Function

Scaffold Protein Function

As a scaffold protein, 14-3-3 theta brings together signaling molecules and regulates their interactions:

Kinase Regulation:

Binds to and regulates numerous kinases including PKC, Akt, and ERK
Controls kinase activity through spatial sequestration
Facilitates kinase substrate targeting

Phosphatase Interaction:

Associates with protein phosphatases including PP1 and PP2A
Targets phosphatases to specific substrates
Modulates phosphorylation states of neuronal proteins

Signaling Hub:

Integrates multiple signaling pathways
Couples receptors to downstream effectors
Provides specificity in signal transduction

Anti-Apoptotic Function

14-3-3 theta plays a critical role in neuronal survival through apoptosis inhibition[@wang2019]:

BAD Sequestration:

Binds to pro-apoptotic BAD when BAD is phosphorylated
Prevents BAD from inhibiting anti-apoptotic Bcl-2 proteins
Promotes cell survival under stress conditions

BAX Regulation:

May interact with BAX to prevent mitochondrial apoptosis
Protects against various apoptotic stimuli
Critical for neuronal viability

Caspase Modulation:

Regulates caspase activation cascades
Interacts with caspase-3 and caspase-9
Limits caspase-dependent cell death

Neuronal Function

In neurons, 14-3-3 theta participates in:

Synaptic Transmission:

Regulates neurotransmitter release
Modulates synaptic vesicle dynamics
Affects postsynaptic signaling[@daubner2011]

Cytoskeletal Interactions:

Associates with tau and other cytoskeletal proteins
Regulates microtubule dynamics
Maintains neuronal architecture

Signal Transduction:

Couples receptor activation to downstream pathways
Modulates cAMP, Ca2+, and other second messenger systems
Regulates neuronal plasticity

Role in Alzheimer's Disease

Tau Pathology

14-3-3 theta interacts extensively with tau pathology in AD[@shen2008]:

Tau Phosphorylation Regulation:

Binds to phosphorylated tau at specific sites
May protect tau from dephosphorylation
Influences tau aggregation propensity

Tauopathy Connection:

14-3-3 proteins colocalize with neurofibrillary tangles
Detected in brain tissue from AD patients
May promote tau aggregation or be part of protective response

Tau Kinase Targeting:

Interacts with GSK-3β and CDK5
Links tau kinases to their substrates
Modulates the phosphorylation cascade

Amyloid-Beta Interactions

APP Processing:

May influence amyloid precursor protein metabolism
Affects amyloid-beta production indirectly
Modulates secretase activity through signaling

Neuroprotection Against Aβ:

Protects neurons from amyloid-beta toxicity
Reduces oxidative stress induced by Aβ
Maintains synaptic function under Aβ stress

Biomarker Potential

14-3-3 proteins in cerebrospinal fluid have been extensively studied as biomarkers[@benzinger2005]:

CSF Detection:

14-3-3 theta detected in CSF of AD patients
Levels correlate with disease progression
Part of biomarker panels for AD diagnosis

Diagnostic Utility:

Combined with other markers (tau, Aβ42)
Helps differentiate AD from other dementias
Ongoing validation in clinical settings

Role in Parkinson's Disease

Alpha-Synuclein Interactions

14-3-3 theta connects to α-synuclein pathology in PD[@qureshi2013]:

Aggregation Modulation:

May interact with α-synuclein oligomers
Could influence aggregation kinetics
Role in Lewy body formation unclear

Phosphorylation Regulation:

Targets α-synuclein kinases/phosphatases
Affects pSer129 α-synuclein levels
Modulates toxic species formation

Neuroprotection

Dopaminergic Neuron Survival:

Critical for survival of substantia nigra neurons
Protects against 6-OHDA and MPTP toxicity
Maintains mitochondrial function

Oxidative Stress Response:

Regulates antioxidant responses
Protects against ROS-induced damage
Maintains redox homeostasis

LRRK2 Connection

14-3-3 proteins interact with LRRK2 pathway:

14-3-3 binding to LRRK2 regulates its activity
LRRK2 mutations affect 14-3-3 interactions
Combined targeting may provide therapeutic benefit

Other Neurodegenerative Disorders

Prion Diseases

14-3-3 proteins in CSF are established biomarkers for Creutzfeldt-Jakob disease[@benzinger2005]:

Elevated 14-3-3 in CJD CSF
High sensitivity and specificity
Part of routine diagnostic workup

Amyotrophic Lateral Sclerosis

Altered 14-3-3 expression in ALS
Detected in CSF of ALS patients
May serve as disease biomarker

Huntington's Disease

14-3-3 proteins interact with mutant huntingtin
May modulate toxicity
Therapeutic targeting under investigation

Protein-Protein Interactions

Key Interacting Proteins

| Protein | Interaction Type | Functional Consequence |
|---------|-----------------|------------------------|
| BAD | Phospho-dependent binding | Anti-apoptotic |
| BAX | Direct binding | Apoptosis regulation |
| tau (MAPT) | Phospho-dependent binding | Cytoskeletal regulation |
| α-synuclein (SNCA) | Direct binding | Aggregation modulation |
| GSK-3β | Kinase regulation | Tau phosphorylation |
| PKC | Substrate binding | Signal transduction |
| Akt/PKB | Direct binding | Cell survival |
| tau | Binding | Neuroprotection |

Signaling Pathways

14-3-3 theta interfaces with multiple pathways:

PI3K/Akt pathway: Cell survival signaling
MAPK/ERK pathway: Gene expression and plasticity
Apoptosis pathways: Intrinsic and extrinsic
Cell cycle regulation: G1/S and G2/M checkpoints

Expression Patterns

Brain Regional Distribution

14-3-3 theta shows region-specific expression:

| Brain Region | Expression Level | Functional Implication |
|--------------|-----------------|------------------------|
| Hippocampus | High | Memory formation |
| Cerebral Cortex | High | Cognitive function |
| Cerebellum | Moderate | Motor coordination |
| Substantia Nigra | Moderate | Dopaminergic neurons |
| Brainstem | Moderate | Vital functions |

Cellular Localization

Neuronal cytoplasm: Primary location
Synaptic terminals: Presynaptic and postsynaptic
Axons and dendrites: Cytoskeletal association
Some glial cells: Supporting roles

Developmental Expression

Embryonic brain: Early expression
Postnatal brain: Increasing with maturation
Adult brain: Sustained expression
Aging: Altered expression patterns

Therapeutic Implications

Targeting Strategies

Agonists:

Enhance 14-3-3 theta neuroprotective function
Promote neuronal survival
Reduce apoptosis in neurodegenerative conditions

Modulators:

Enhance anti-apoptotic binding
Promote tau interactions
Modulate protein aggregation

Challenges

Scaffold complexity: Multiple binding partners

Isoform specificity: Selective targeting needed

BBB penetration: CNS drug delivery

Balance of effects: Protective vs. pathogenic roles

Biomarker Development

14-3-3 proteins continue to be developed as biomarkers:

Blood/CSF 14-3-3: Disease progression markers
Combination panels: Increased diagnostic accuracy
Longitudinal tracking: Treatment response monitoring

Research Directions

Unanswered Questions

What determines whether 14-3-3 theta is protective or pathogenic?

Can targeting 14-3-3 provide neuroprotection in established disease?

What are the downstream signaling consequences of 14-3-3 interactions?

Emerging Research

Single-cell analysis of 14-3-3 expression
Structural studies of 14-3-3 complexes
Development of isoform-selective compounds

External Links

[Ensembl: ENSG00000108774](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000108774)
[NCBI Gene: YWHAQ](https://www.ncbi.nlm.nih.gov/gene/10971)
[GeneCards: YWHAQ](https://www.genecards.org/cgi-bin/carddisp.pl?gene=YWHAQ)
[UniProt: P27348](https://www.uniprot.org/uniprotkb/P27348/)
[OMIM: 609505](https://www.omim.org/entry/609505)

References

[Foote & Zhou, 14-3-3 proteins in neurological disorders (2020)](https://pubmed.ncbi.nlm.nih.gov/32044123/)

[Yau et al., 14-3-3 isoforms in neurodegenerative diseases (2015)](https://pubmed.ncbi.nlm.nih.gov/25967282/)

[Wang et al., 14-3-3 proteins in neuronal apoptosis (2019)](https://pubmed.ncbi.nlm.nih.gov/31028976/)

[Steinacker et al., Neuronal 14-3-3 proteins (2011)](https://pubmed.ncbi.nlm.nih.gov/21246692/)

[Umahara et al., 14-3-3 proteins in Alzheimer's disease (2004)](https://pubmed.ncbi.nlm.nih.gov/15582247/)

[Kim et al., 14-3-3 and neuronal survival (2020)](https://pubmed.ncbi.nlm.nih.gov/32296148/)

[Satoh et al., 14-3-3 proteins in brain (2007)](https://pubmed.ncbi.nlm.nih.gov/17703388/)

[Benzinger et al., CSF biomarkers for CJD (2005)](https://pubmed.ncbi.nlm.nih.gov/16226162/)

[Berg et al., Human and rat 14-3-3 eta and theta proteins (1989)](https://pubmed.ncbi.nlm.nih.gov/2552033/)

[Ichihara et al., Molecular cloning of human 14-3-3 theta (1991)](https://pubmed.ncbi.nlm.nih.gov/1718719/)

[Pompl et al., 14-3-3 proteins in neurodegeneration (2003)](https://pubmed.ncbi.nlm.nih.gov/14518004/)

[Xu et al., 14-3-3 theta protects against neuronal death (2013)](https://pubmed.ncbi.nlm.nih.gov/23867974/)

[Shen et al., 14-3-3 and tau (2008)](https://pubmed.ncbi.nlm.nih.gov/18974710/)

[Layfield et al., 14-3-3 proteins and the nervous system (2003)](https://pubmed.ncbi.nlm.nih.gov/14625395/)

[Matsuoka et al., 14-3-3 proteins in AD pathogenesis (2008)](https://pubmed.ncbi.nlm.nih.gov/18055161/)

📖 View canonical wiki page →

Related Entities

YWHAQ

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-ywhaq
kg_node_id	YWHAQ
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-0ca3e0693009
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-ywhaq'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

40%

Debates

0

Incoming

8

Outgoing

10

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

YWHAQ Gene

YWHAQ (Tyrosine 3-Monooxygenase/tryptophan 5-Monooxygenase Activation Protein Theta)

Overview

YWHAQ (Tyrosine 3-Monooxygenase/tryptophan 5-Monooxygenase Activation Protein Theta)

Overview

Gene and Protein Structure

Gene Organization

Protein Architecture

Structural Features

Molecular Function

Scaffold Protein Function

Anti-Apoptotic Function

Neuronal Function

Role in Alzheimer's Disease

Tau Pathology

Amyloid-Beta Interactions

Biomarker Potential

Role in Parkinson's Disease

Alpha-Synuclein Interactions

Neuroprotection

LRRK2 Connection

Other Neurodegenerative Disorders

Prion Diseases

Amyotrophic Lateral Sclerosis

Huntington's Disease

Protein-Protein Interactions

Key Interacting Proteins

Signaling Pathways

Expression Patterns

Brain Regional Distribution

Cellular Localization

Developmental Expression

Therapeutic Implications

Targeting Strategies

Challenges

Biomarker Development

Research Directions

Unanswered Questions

Emerging Research

See Also

External Links

References

💬 Discussion